<SEC-DOCUMENT>0001193125-15-014048.txt : 20150120
<SEC-HEADER>0001193125-15-014048.hdr.sgml : 20150119
<ACCEPTANCE-DATETIME>20150120080134
ACCESSION NUMBER:		0001193125-15-014048
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20150114
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150120
DATE AS OF CHANGE:		20150120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		15534002

	BUSINESS ADDRESS:	
		STREET 1:		311 ENTERPRISE DRIVE
		CITY:			PLAINSBORO
		STATE:			NJ
		ZIP:			08536
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		311 ENTERPRISE DRIVE
		CITY:			PLAINSBORO
		STATE:			NJ
		ZIP:			08536

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d854281d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): January&nbsp;14, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-26224</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>51-0317849</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>311 Enterprise Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Plainsboro, NJ 08536 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (609)&nbsp;275-0500 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01 Other Events. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;14, 2015, the United States Food and Drug Administration (the &#147;FDA&#148;) issued a letter to Integra LifeSciences Corporation, a
wholly-owned subsidiary of Integra LifeSciences Holdings Corporation (the &#147;Company&#148;) informing the Company that it had addressed the violations in the FDA warning letter dated February&nbsp;13, 2013 related to the Company&#146;s medical
devices manufacturing facility in A&ntilde;asco, Puerto Rico (the &#147;A&ntilde;asco Facility&#148;) and that such warning letter had been closed out effective January&nbsp;14, 2015. A copy of the letter dated January&nbsp;14, 2015 relating to the
resolution of the warning letter matters is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
press release issued by the Company on January&nbsp;20, 2015 announcing the resolution of the FDA warning letter related to the A&ntilde;asco Facility is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference
herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Letter, dated January&nbsp;14, 2015, from the United States Food and Drug Administration to Integra LifeSciences Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Press release issued January 20, 2015</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: January 20, 2015</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Glenn G. Coleman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Glenn G. Coleman</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Corporate Vice President and Chief Financial Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Letter, dated January 14, 2015, from the United States Food and Drug Administration to Integra LifeSciences Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release issued January 20, 2015</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d854281dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g854281ex99_1pg001a.jpg" ALT="LOGO">
 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Food and Drug Administration</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>466
Fernandez Juncos Avenue</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>San Juan, Puerto Rico, 00901</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Telephone: 787-729-8500</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>FAX:
787-729-8826</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;14, 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15-SJN-WLCOL-03 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>CERTIFIED MAIL </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>RETURN RECEIPT REQUESTED </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Peter Arduini
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and CEO </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Integra Life-Sciences Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">311 Enterprise Drive, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Plainsboro, N.J. 08536 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr.&nbsp;Arduini: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have completed an evaluation of your
firm&#146;s corrective actions in response to our Warning Letter 13-SJN-WL-03 dated February&nbsp;13, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food,
Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any
future regulatory action should violations be observed during a subsequent inspection or through other means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should you have questions and/or comments
regarding this matter, please feel free to contact me at the district office address provided in the letterhead. You may also contact Mrs.&nbsp;Margarita Santiago, Compliance Officer at telephone number (787)&nbsp;729-8702 or at
<U>margarita.santiago@fda.hhs.gov</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kind regards,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g854281ex99_1pg001b.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Edwin Ramos</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Director of Compliance</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">San Juan District Office</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Peter Arduini, President and CEO, Integra Neurosciences P.R., Inc., 15-SJN-WLCOL-03 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reviewed&nbsp;by:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g854281ex99_1pg002.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center">1/14/15</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CB: WL Legal File </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FEI:
3000204775 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CMS Case: 392719 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d854281dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 99.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>News Release </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contacts: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Integra LifeSciences Holdings Corporation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Angela Steinway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(609) 936-2268 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>angela.steinway@integralife.com</U> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Integra LifeSciences Announces Resolution of Warning Letter </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Related to its Manufacturing Facility in A&ntilde;asco, Puerto Rico </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Plainsboro, New Jersey / January&nbsp;20, 2015 &#150; <U>Integra LifeSciences Holdings Corporation</U> (NASDAQ: IART - news) today announced the United States
Food and Drug Administration (the &#147;FDA&#148;) has informed the Company that it had addressed the violations in the warning letter relating to its manufacturing facility in A&ntilde;asco, Puerto Rico (the &#147;A&ntilde;asco&#148; facility).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The A&ntilde;asco facility had been operating subject to an FDA Warning Letter dated February&nbsp;13, 2013 that related to quality systems issues. After
concluding its recent inspection of the A&ntilde;asco facility in September 2014, the FDA determined that the Company&#146;s remediation activities were effective and its quality management system was adequate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Over the last few years, we have made significant investments in both people and processes to enhance our global quality assurance programs,&#148; said
Peter Arduini, Integra&#146;s President and Chief Executive Officer. &#147;The lifting of the Warning Letter at our A&ntilde;asco facility is evidence of the progress we have made in improving our quality systems throughout the Company.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please refer to the Form 8-K filed concurrently with this press release for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best
patient care. Integra offers innovative solutions, including leading regenerative technologies, in specialty surgical solutions, orthopedics and tissue technologies, and spine hardware and orthobiologics. For more information, please visit
<U>www.integralife.com</U> </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g854281ex99_1pg001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g854281ex99_1pg001a.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`30+&`P$1``(1`0,1`?_$`)(``0``!@,!````````
M```````!`@,%!PD$!@@*`0$`````````````````````$```!@(!`P(#!0,%
M"0P+`0`!`@,$!08`!Q$A$@@Q$Q05"4%1(A8787$R@9'2(R12,U.3-%24)371
M8H*RPM-$528G&!E"<I*BH[1%U3961PH1`0````````````````````#_V@`,
M`P$``A$#$0`_`/OXP("(!U$0`/V],"RS]D@*LR3DK'-P\!'K/F,8D_G)-E$,
M3R,FY391C`KM^LB@+R1?+$102`>]54X%*`F$`P-?EZ^H)7WM2\CUM&T2>ONQ
M_&.<HD3?:3;(Z>J:Z9+3<'E:G%HYDSBYBRS#VOLH9^LDU:LCJ21@1*V%0BP&
MP,,F\S?,Z0DZ_&0'B4[,D_VKY#4:P3,M1-MLX:J5>A-43Z/MLBNNW8`LEMR2
M<()+`W%9!D"@G$Y?:4``OD)Y_P"TZU88ZO[@TI7J@ZLL9#V:%962V'U"YK,#
M^4H:YV^$L\SL47E2F-@5F&L#42Q<7(#[ZR#U)0R`M#&,'L[07EMIGR1CX5SK
MJ;>I2\[2(;936FV>.6@KDCK^R.U6M:N#N&.9P1*#LA4RKL5BJG^(;+)*@`$4
M*(AZ:Y#[_MX_E^[]^`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&!@'?F]JGI2`9JS3YF>QV%=5I4JY\0T^<3Z[)'XR7
M5AHMV\CC6%W`Q":\@,6U6+)2:+11!B15T)$C!K+I'B=O7S:>6K8'EGMBX(^-
MVS(R@I0/C4A66E:&;BJ7:U[A\9:E)&%CINL-5[HR*XAGC9!G87=6<I-Y%4BQ
M`$`VT:OU#KO34"-9UM6&-9AE%U'CE-$[Q_)2+Y<YE%Y"9GI9R_G9V07.<1.N
M\<+K&$1_%@9(#N[AYX[>`[?7NYY-W<\]..../Y<"R6&LP-KCU8BRP\3/Q+@I
MR.(N;C&$O'."J)J(G!5G(MW+<_<BJ8H_A_A,(>@C@>4[MXFUB$INW">.+2.T
MSL[9$!&QJ5IB7]GC(=@,)%.*_&1S*,A'XH5>);5Z0=H-B1+5$K!VX*_11%TB
MF;`P9XV>55H@=IS_`(W>1\S5*M>8Z->N=9P$FH[)M"X0=,B7DS>[4>%C'5J)
M^E,1%)(IP$S+/$)F72;*'=D4=&,(AL/H=[I^SZ;7-@Z_L<5;J5;HIM-UJRPC
MDKN*F8IX43-WC-<O'<F<`$!`0`Q#`)3`!@$,#MN`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P..Z<HM&ZKEPNBV01*)U5W!
MR)((D#^)1510Z9"$*'41$P!^W`U-5_6=@\R_)Z\N/+;PF2U?&>,-OAQTIN,;
MX2R,]S0H2+R8BXDT6>`0C96IG$&TTY(BH)XZ532;"H"J:HG#;8`<``<B/'3D
M>H_RC]HX$<!@,"RS%A@8&+F)F<FXF&B(%FX?S<K*R+2/CH9DU1^(<O)1\[52
M;,&K=#\9SJF*0I>HCQ@?,+Y9^<-M^H7N9]XR?2_UPO;KNC79O5^R?-7V9"'K
M]`UA=)&&/=8^J3Q"M_E4+,*U]N)I=7N>.TDC(Q:)_=%40]U^"OD9IC2.WM3_
M`$G=&/)'=\=HO1EFD-G;N@54GT#4]CQME4D9.MS9F0*1[5O)/Y5X4.Q4WP3I
M1LRY44]X4@W4X#`AR`?O]>/MZ<<]/7IS@0[R`(%$P`8>H%'H(ASV\\#U]<`)
MREX$P@7D>`[OP\B(\``<\<B(^@?;@1$P!T$>.O'\O'/KZ>F!3,NB3^-0I>@#
MU'CH(B`&_<(AZ^G3`G[R\"/(<!U$?L`/OY^[C`B!@'J`\AP`\_9P/H/[AXP)
M053'NX.0>TW8;@P#VGZ_A-]QNGIZX$OO(@)`%5,!5'A,#'*45!#CD$P$0[^.
M?LYP)A53+SRH0.![1Y,'0>@<#UZ#R.!3.Y;IF[5%T2&$P%`IU"%,)C``E*`"
M("(B!@']PX$WOH]!]Y+J82!_6%ZG#CDH=>I@Y#IZX`ZZ"1#J**IIIIE,=10Y
MRD(F0G\9U#F$"D(7CJ(B`8$J;ILJDFLDX0415*4R2R:J9TE"F'@IDU"F$AP,
M/H("/.!,1=!0QB)K)*')_&0BA#F+_P"L4HB)?Y<"4SIJ4PE,X0*8.>2F63*/
MX3E3'H)@'HH8"C_OAX]<"47C,`$1=M@``,(B*Z0``%'M,(CW<`!3=!^X<"H1
M=!0H'3534((=P'3.4Y1#[P,41`0P)3.FQ``3N$"`8W:`G5(4!,/<(%`3&`!,
M(%'IZ]!P*:K]B@B9PN\:HMR@`F<++I)(%`0`0$53F*F`"`AQU^W`XQ9N&.(@
M27BS"5+WS`5^T,)4?\,/"H\)=?XO3`J!+11BD.$G'B103%3.#QN)%#$,4ABI
MF]SM.)3G`!`.>!$`^W`YPF*!>X3%`H>IA$./Y_3I@<1S)1[)(J[Q\S:('.5,
MB[IRBW1.H?\`@3(JJ<A#'/\`8`#R/V8%!W-PS!0R3^7C&2I$#NC)O'[5LH5J
MF(`=R8BRI#`W((\"?CM#[\!'SD++"N$5+QDF+4X)NOES]J]^&4-_"1Q\,JK[
M!S<=`-P(X$74W#,7*#-]+1C-XZ$I6K1T_:MW+DQS=I"MT%E2*K"8W0`*`\CT
MP+::YT\I'"AK76BILU00=J&G8L"-5C&4*5%P877:@J8R1@`IN!$2C]PX%=:T
MUEL9,CBQ03<ZK%232(O+,$CJQJ0`9613*HX*)V"91Y,L'*8!ZC@54[%7U8SY
MVE.0ZD-V&4^;IR3,\7[9#BF=09`JPM`(10.T1[^`-T]<#D-9>)?,4Y1E)Q[R
M,6(*J,BU>MG#!5,!X%1-XBH=N<@"'J!N,"1].0L8=HE)R\9'*2"X-6";]^U9
MG?.3!R#=F1PJF9RN(#_`3N-^S`F2F8A=^O%(RD>K*-4DUW4:D\;J2#9%41*D
MLX9%4%RBDH8H@4QB@`B'3`X06RK#,GKH66`&P)HIN%(()B.&9(@L`"DL>+!Q
M\<5)4!#M,*?!N>F!P$=@4-R_3BV]VJ+B357!LE'(62&5?J.1.9,&Z;--Z9P=
M<3E$O8!1-R'''.!4;WND.Y$L.UN55=2YW*C,D4WL,0O)'=H]WNM2,4GAG1G*
M78/<F!>XO`\ATP+BC8Z\YD74.WG8=Q+L2`J]BD))DK),TQ`H@HZ8)K&=MR"!
MPZG(`=0^_`MJ=[I"QV*2-RJJRLHX<-(Q)*PQ*JLB[:.!:NFK!,CLQWCELZ#V
ME$TP,<BGX1`#=,">2O%*AY5I`R]OJ\5./T`=,863GXIA+/&PF$@.&L:Z=I/'
M"`G*(=Y""7D..<#C26Q-?PSE1E+WJG13Q$J9E6DE9H1BY2*L0%$C*(.GR2I"
MJIF`Q1$`[@'D.F!S7URJ$6Y8LI.U5R.>2:8+1K1_.1C-S(I&$0*JQ0<.DU7:
M1A`>#)@8!XP.R8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8'B?SZ>W=7QWL]2HM?5LSJ]R$74K;',G=#:S+75[XKIWL^7@"[,`]
M(>3493F+DR"4@11$5#EZ`;M,`=L\*-7#I[QBT[1UK%<[2\;4^.EWLQ?GDB[M
M*JT\@233:RB4C9+<$6K%M7";46C9^LR0.D8J':GP4`]68#UP&!Y6\KO,WQ\\
M,-?*[&WQ?HRKL%4G05VN)'(\N5VD6R!U_E%1KI#E>2CH_:!3*?@;(=X"JJF'
M`B'S`0.O=[?4+H6R-J[MV9L#PW^F0MLB<VK89K;=W54L5\ASR3QRWAJJP729
MLGL9W*I`F\=%<,?BB^VU1=*)DP.XT/8&T?,*O3_AG](_6[#Q*\%J8DC%;G\O
MK(U>URU7-DW;J%L3YW8U`0E'$G+QH'.=/WCS*J)A%PM&M?ZO`W.?2;TUX.:K
MTI9"^%TFGL)JPO,]KS9^[Y)H92R[,O-+^%^:NR3"B94EZB122!6-28C\N!-3
MN3[S"94X;6\!@:E/K,2LM"^,&LG\++3$*[4\N/&>)<O(*7DH1^K#S>P6T7-1
M@NXMRU<JLI6/<G070$PIKI'$A@$!XP/*.XK/?*7OCZK&D-?3]E<^.]9\"'6V
MU(U.:EWT7I[R#E*_+`VBZ9-JNEG54<6*`;&F%XMNX2315(5P1-,!#N#(OBM#
MLU?"9*_7&$:TN\V?PE>1E!E&&PYZPR>Y8%QHFO7:T7^PI/7*95K;$W1!4XK$
M2*XC14[1<J>\7`L7TQ]:;2+J?Q&\NY[8WY#U%!>(,JQVK6W%QL-N?;PL+IP,
MK&;4O02YB0D(ZI<:R74(L!G4HN=8R:JWM%`@AW?Q.\FMKQOGGLO4>_BW")J/
ME]28W?7C='WN!=5A"KR=,C6M<NNFJVD^<KIRY&5.2CY51=(4P7<"X/[0=_4-
M7FH]BV&`6U;'OYBQ:;K\M]6G>-='S'4N4O+1=6AZ;;%QC?&:S5\KHHL*[L]H
M[)&1P22QH%L0%#^V15,.`V8^6FJ=>5_ZAOTYZRVC%OD&[;MY73.U(UY8;`LA
M?9-77R,W$HV!N$C\/*,H&0=C\M0.46[(I"%1`@`&!U#RJJ=I\:_)35_DOHMI
ML.QQ7C,V\=M0[$U7"6&7F5-CZ:W(QO\`K5BO(1<B_.QE+37;<SA1"2<D,Z]K
M\9U!!$,##5.KUAK=D^N]7KC;IBTV^O:"HUG<2KV=D7Y(&W6K0-SOEG-4BJ/C
M&K46QN"P`P2:`B"23-`0'N(`X&>?$NOU8/"V*MU^@*C5;[</!YS"4"0A[E(2
MLKN>FFT56[K=[C<TC';'=VB)NC%0ZCA1+WHLR@D3<J>_U#'6IZ5M[QSW?XK>
M&NP_S3N3QFVA?%-M^,>\K%*/92V:Z00U!>Y2[:'O$XNLJ\D'K!Q+)2-?>BKW
MF;ICR!C)<(!D/76@=.NOJQ;[T:M54/TXK7A%HRQ5FLI2DLBG`V5KL-1K^:XU
M5)^1RVMBH,6XK2)!!RO[8>Z<P"8!#.GGE+6YUYG?3GUM;%WC3Q5OVPME?J>W
M%15M5;AM.$I2\AJ&E7]<OMM'<,]E04<LHYR;X:1?(@4Q%#$*7`\6^0+FSU_8
MWUC];:U<.6_C/7_!Z,NKF+C550I>O/)1Y5G[MVUI1TCECJI.S-5*63DV3$4/
M;=$0<F3(J?N,'OSZ:NIU&^IM/;6L^NM?5N8'Q]U$PH=SH;^1<R=TK5OUY5IJ
MYN]BNG:#!:6MJEPCO=5!=-<C<P]R"Y_=5$0\0N#6Q;R^^M^QK+6DR<3&:3U>
MN_2MT]+L5H-&2\?K#)R3JLM(Z)EVQ%G4HD9PX[S-2B\33,)A/^(H>:VY'DAX
M_?\`^?A.$9U&SSUH+>FQXJ^R:[>I7667TS(R#1C>7:";]S*L'%C3(J<%DW`"
MZX./"G!@#<58IF#J_C(CI30BR<1LO9TQ.:R=1FJSPT^]UO?++")VO>4U3HQ_
M.1T*8-:M)=TY(T;O2M63M5!$!+P">!JRV+O^S;.^AUY8:]VL^6B_([Q#^6Z"
MVPUD)!!*SI3NO]ATME5+<^^%=KJMG=IIAD3BN1=7WEBN!!4X"(X&\F'E]"[6
M@=4Z.GG%8OCQ]KZK[+"FLEV4W$DB:&:K)LY2QM&+A5F2*)8I)J5!!R0R+M9,
M0[3`F<,#4!X*:NUC-^%/G;?'U<KJMQHF]?J(5^KV4I&Z3^)KKF+F(I*",]04
M#OK[9D)?AFJG+9L9,IT2%,4#8'GO7[NWO/'#Z`:T\:@_E5WY!ZU1BE(V0FW%
MGE"GIEJ%T6TIOT4V"Q57#<JKKL.J`O$T?XN0P-_GF#8YEUJMWIFB/9U'8^^6
ML[KNO*U$80]P@*\XAW)[]>8)I89>!CG+JI5E0YTA,Y3[7KAOU$1`,#5CIFWL
M/+WZ=Z7BAY/*.&^T-,;^UGXC>048K.MV%L:N*_LF"@JW;VL@Q>JN&4I.5,6Z
MZ+M%=4%7:"X@<Y`.`APM:DWS1)GRD\8?**._.]A\;_!'=[/4WD=)H(*J;OTK
M:WK3\G/I07*)_AKM30@CQDUVK&!9<$SF*`CWJA@KQ@6E&\#]#-YXX*(&VE.4
MM\S\F4J88JB$GX\-JTW_`#*]W,G%B=HJ2.L8E^4KRG]J"6,<$#"?W0P/>7G.
M6:_\R_Z7(55:HHV)1EY4@U"YH/5H5;VZ!`F0*Z+%JHR!G29S*"SX_A<CZAR;
M`U@WF&F9_P`+?KB1R47"3ERAO-UM8Y9&AL5W;=M&Q4]JZ7EI2&;F^)FDX./:
M,9!;E01]I--<>>`/@;LKU8M<WIY.V:HR5(M<+!>!>V$I.>A5X>8A89M9QJ3N
MOQ[R88"X:1Z$PP@WRB+?W2]Z#90W;V@`B&G"6U)L#5GC)]0?Q!3C7J?B/3=*
MO?,34EU1>*K,5X;:^N9*4KVBV"_N'4D&D)M^$=2P"FH8OM1::1R\.R\A[=M2
M5WW)]-?QG\4=`NGQ-C[7\/:+;'SRESM2A)JJUBFT:NJ,9,ZMAE8I%-A9MIJ1
ML6\.B8SKX,'_`&E%4.0#A)6/77U4?"_Q%@MO/G%<NUIV9-4+8"\-*A$7/6GD
M1K+5.R45K)6G":K5XVE8NY0K:8:ID'VEFZY"'[BF#`]$?3OD]]K[3\D:'Y45
MZ/\`UNTG7M*:M<;3C&?PK#?%'8FV7*5';;$QT2KD/9(YV1.10%54J4FV6+^`
M0$H!Y?1_/VF/(QC8:I+ZH\N/'/<OFX8TC19E@$/Y6>-6YIZZN8V1GJ]+H*J.
M;E0Z3-1:JQFSU)([.O)F,0_PA><#IGA8&M8W<GFC-;%5T6?6T)]1/<SUF@^C
MF!MO.=HGL6M/T>=4QWWD>.H+YV5TBS0CB`J=\<PG,9'W2@'CG="TJUF?J9F+
M6($=-#]2;4JVZ=PTAF=_NW0%&;1E%D5MJ:ZC6[<K4[:.DXOX!V]*Z348F<.E
M135X.!0V=>3;>U:-\O?&CS/\;*^EM*%\IZ67Q*V,C7UVCUA8IF=C5K3X[;;D
M)E%-5)>.AY1DLE)N^G,6GVA^(2A@1\GM<U+4_EQ]&FFPZ$8#>K;0WW'N71VK
M%)1]+R6I3+/+&]`I"E1?6.UNUG*B@=HG>N1[?QB`8%L^G.6@N=2^3E8\UDJR
M;R8D=_;@;[]CMLI1QKA-5>5DR(Z["O-Y<%9)]K=>FK-D:\2(`S(@`)6P`L(\
MACR]PM7:_5:W!$IN-)Q-!3\+_'-A=`W)'LG3)SK*'V@^0O$3`O;`X;1[*UFH
MQQ(H9Z"ZI6O`@4JG:<H7;R7=352M&SO(/QJMVH]U:V?ZET[![;\)=V0RK.9N
MU`B:PT<:]E_'NU")K%&SDU5;04Z#$4%FSV3(7GAR)0P-\\&[7?1$8\<1[F)5
M=1K!TI&/!(+R-5<M4UE(YV)#&(9RQ,?VE!`1`3E$0Z8%VP&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!J_P#JG6.DUW2E;-:K;K*F
MRLE<3L:C);)U',;0.O(G@GHRT=19.(93(ZRO[VO?%%C9U:.?(I..U,R8=_<`
M>_=44"!U?KJG4*MJRSB&J\$RBF#N>E'LU,O4T4P$[Z2DGZBCET]>J&%501X`
M#'X*!2@``&0\"`%`H<!S]OVB/J//VC]^!BG>>U8?1VG=H;AL(H?)-94"VWF0
M*Y<E:(N25N%>2B4>+DY3`B>2<-R-R&X'@Z@=!P/C\TS6]9WC16P?K2?5%5LV
M]'$ML&0A/'W0R[T[:G2\BRDW+6!AFD.X5&/3KC>:9.D6;$Q4XY!I&KNW";HZ
M@$P.]SE$V%YJ5=KYU?5LV>X\7_!NNBU7TGXJU9Q)0#F],4VXKU="M5PASO3*
MS2#@B(/3M?FKXA.Y$L>R$JI0R'J>O>4OU>64)JS3M3=>!/TIZ&\-%Q\?3XP8
M*T[7AXLY6@P)7""Z9+*_>E,<70IB:$;',<[H\BZ*4HA].F@/'[5'C)JVKZ<T
MQ4VM.HM2:JH1\:W55<N7;MRI[TG-S#]8QG$I-S+OE9RY5$3'./``4H%(4,T8
M#`QGM*GZBN\(QAMR5^B6:NIRB$C'Q>P6<(_APFF2:AFCUJTG@,S-)LR',9)0
MH"JD/)BB`AS@6B%I>A9&M3>OZ[7=7R%3L";M6RU*$95M[#SJ;TI6[Y:P1#`J
MJ$L5T3M36.Z(I[A>"F$0X#`DA_'70E>(=*"TUK.'2/7I"H^U&TNOLDB526,B
M>4K**3=@F1"`DC-DQ79D`K=;L+WD'@,#L[#5FLX>C*:SBZ#48S7!V3J.4H<?
M7HQG4#1SU0ZKR/\`RVV;)Q/P#I14PJ(^S[9^X>2B`C@6!SK_`$=<[)!2+VI:
MYM%OUJ4K:MOG,;`S-DU_RFFF",,X.1S*5,YTDR%$$1;B8H`4>0X#`HI>.V@T
M:O.4=/2^KBTJSRX6"QU#\BUL:O.6`JQ7`3TM7S1PQ+^;^(3*<7BJ)G`G*`B?
MD`X#L4IJ75\Y,U6Q3.OJ?+6"B`4M(G9*O1;V9IX%2*@`5>4<ME7L"`HIE(/P
MITNXI0`>0``P.:ZKU`KLA.7=]$5>'DY9K&H66UO&L:Q=2#*%.=6(3G)IR"1G
M#:*54,9M[Z@E0.81)P(X'2SZRT`Z;7"S*4/5Z[+8<?WWZQ'K];49WF)2."_N
M6Z8%L9O98Q,0YY>*K)`4./X<#K=5H/B>*Z\11JCH11T^KK^M+1E2B:$HZ<U-
M\5,\I7P90Z0KGKSI,I17:`7X8Y0#N*(`&!FUO6*T@R@V#:#B4V%9,W/6VB;%
ML#:!.T9+1K56%3!/LC5&\<X403,CV"5%0Q`$"F$!"W-=>4)C;'E]9TRKM;S(
M-2L)"YH04:E:W[`@$*1@]L)&P2SM@F"9>U%18R1>`X*&!<;)4ZO<HM>#MU=A
M+1"N5$%7$188ME,QBRS54JS591A((N&IEVJQ`.D?L[DS@!BB`]<"Q-=6:T95
M=[2&E`IS>F28K#)U-*N1):W)F<]GQ)Y*#!K\MD%'7ME]TRR1S*<!W"/&!?Z_
M&UR`8I5RKQT3#14$4C!O!P;5HPC89/VB.4F2$:P*DUC4_9<%.1(I"!V'`0#M
M$,#'MCKVAZBZE9FVPFJZR\V(O\EG9:P1]5AG%Z<N`%4(>9D)!)LI9U%RI_A;
M.#K]P!P!1],"Z*:9T\Y81$:MJO7*\7`I+IU^.6I5<580*+Q3WG*<&S4C3-XA
M-TJ/>H#<J0'/U-R/7`Y04G5E.9M)-.I42K1]23FI=C))0<!!,JLD]2,XL4HV
M>IMFJ$&F]03$[U<ID@5(3E4P@7D`X##7FF;+&.Y..HNMIV&N164P_D&E9K,E
M&6X@_P!MCI9Z[29+M+$03+>\@X4,L'<;O*;D><`P@=+ZYG(N'B836=$LEU*Z
MC86,BXVKU>;MJ<4D:1?L(QHS18/IY*,;F%PLDD54$2"*A@`.N!V!G0:%$1TG
M%QM+JL9$3*JZTU%QM>BF4;,+/``CI65CVK1)K)JN0Z'%8B@G^WG`I(ZYUT5O
M#H(4.FIM:^NJYKZ"=7A4T8)TJL"R[B&1*Q*2*<*N"`<QT`3,8X`81Y#G`OSB
MO03Q^QE'</&.I2+!R6,DG+)NO(1I7A2D>%CWJJ9G3(KLA0!4$C%]P`X-R&!U
M=S3M8QH2DNZJ%+9`=<9B:DUJ["MO<<1@N'?S>4>J,TQ57CQ,JL#E4PF1Y,?N
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MBXXS!-)%%-B9FW,R(BW-W-TB-!3%N5-`W4@`7@OV<8'';UROM%$EF<)$LU4&
MIV*"K2/:ME$6*BIEU&21T$DS)LSK'$YD@$""<PF$.1$<"FE5:RW%(6]>A&QD
M%Q<H&;Q;)`R#DR?M&<H&10(*+D4OP"H7@XEZ<\8%X3012$QDTR%.8A$S'XY4
M.1,3BF0R@\G,1,5#=H"/`=P\>HX%K)6Z\G)!-$@XDDT5N=H$P2.:$E@:J&$R
MC<)(J0/01.81$2]_:(CZ8%(M4JY5DW)*Y!D<I")D7*<2P3<HF%05A.BX(@59
M)05A$_<4P&[^O/.!RTH.&1!<$8F.2!T42.O;9-R?%$,<5#%<]J8?$`8YA$>_
MNY$1$?4<"NE&QZ"2*"#-LB@V$HMD$42)(MC%Y[#-TB`5-`Q.X>!(`"'(\8$%
MHR/<'(HX9-7"J0\I*KH)K*I#W`?^J55*8Z?XR@/X1#J'.!QUX&%=.VT@YBH]
MP_9@8&;Y=H@L]:E,'`E;.U"&<-R_L(8H<X$BU=@')Q4=0L4Z4,?W3*.H]JY4
M,IR(]XJ+I*'$P"/0>>F!.M`PCA=HY7B(U9S'G*K'N%F+95=@H0@)D48K'3,H
MS.1,.THIB42AT#C`NH%`OH''\H_M'G]X\X$<!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:__`*BU8-.:+3E%_(U/Q6BZ[<8!Q+;?
M6F[7%-HR.E##"C"+MZK+P"TD-CD'Z#(J3ET1N0%A4*`K%2$H>Q=8V")M&O:7
M.P5FC;I%2-:B%6ENA5E7$39"ILDD%9F/77<.UU6K]PB=0@G55.(#U.8?Q"'>
M\#5IY;_6'\+O"W;"NE=P3U[=W]G!1<_+1='IBEE0@VTT4Z\8UEGIY*.10D7C
M$I7)42]YO84(81Y-Q@:F/J$_61\;_-+Q"OGC+XEEVK:=Y;WEJGKR#ILAK.29
M/G42_L\0\F3IKI/';,QGS!D9!$$E3K`93DQ2D`Q@"Q^>^EHZGV+Z(OT[;8G(
ML-4,YVKDOST5F\DULEB:OJK"S<"ZKL<LHZ<JF=NGZ8O%6_PY$I4XD5,(+\!W
MZ>T54?J0_6BW+JG>A)5;07A!KBI-ZAI]%VLUK-A=E+7`(DY:-C%;,(*7DYY5
M9VF@":SMHQ;M^X$N\I0^GB!@8>M0\9`0,3&04+"M$8^(AX9DWC8F+8-DP2;,
MHY@T20:LVJ"10*1-,A2E`.@8%XP&`P-,7U^&J*_TS=O+F02.Y9V[4BK)T9(A
MEV"RVR:XU47;+\>ZT.HV7.D8Z8E,*:ABC^$P@(6E39[?QC\?][>96P/&>NT*
M]^,U$B:3K*$J#J%)^I-'O%"TVZ8KSMM@(*/0E(N;V,Z]U03(G7AR(JI\F4[N
M0H[/^J9;M`L/*BN;'I,'<MBZ%T?X_;BJ;NJ-9JMU*T+>0<C'5:,KMA0?/YY]
M$-JE<9-,%79''+V-`P@1)<HA@3[E^J#?/'M#R]H]XI=6N6R_'>(\8Y&G3D$T
MGJ]2;>?R<<1<+'-[1'*R4Z_A"TJ>?G,M[#T3R#(A1("*G<.!Q_$:.M,=]8GS
MX1N+ZO2<^'C5XOJOY.J0SJNPTHH[:NEADAAG,E+';/USE,50?B%NXI"CW>H`
M';/J%?4)W+XAS.S7%5JVN)6"UK2=2WV(B9%X]M%EO[*X[%0I5Y:62.K<JS?Z
M=@:\U=H#%3,D@JWE9!444@4[#$*&/O*#ZB/E#K#<_DUKW5T!I=2K:*\(H?S#
M9R%ZA[E)65\91VS:R%(!*!LD7&OP>+J'`CL2M0;)F`1(J)>H<+R"\T=A[WI5
MGT=4J_1ZPC</I3VSS+V.YM;&8LQ'!+Q4U(N-US52HO(I%D1@9XY<JR:Y7"I3
M)H)D1`1.;`]K_2S9-'7TX?#IJY;%=,W'C_2T5FSY,%R+(K,%`41<(KD$JJ:A
M#B`@8H@)1X],#YS]8UVK1OT)/);;K-)&H;3T_P"5^QKIJ?8<$5*$N=8NT?M&
MBLHHD+/M$TI1`CIO)K-3MB*>TLB/8)1*`8&VUOYC>=,_NCQQ\:M<PVDFE^W#
MX`5SR.EYG<$;;VI*MLQNE&1TVSED:O*`YD8R3DC=HMB-D%6BK@QCG.5+VSAT
M/='U+/*C4<']0Y8([3\O->&VVO%>E5COJUF+%V2*W>DQ2M2<PD6V(O?B&#U\
M(Q[E(Q.")`"J(B81`._>4_GUY;:]V9OC7VI:!62636L;XS*:3H<U2[%<[)Y-
M?K;-#%WNQUA2'GH@K&%UT)5$O:0*<4%6RJCU1-$2B`;BI>UIT#6<A<[W(D7"
MIU)Q.VF09L?@0<KQ4:9W)_+XM)S(G24=.$C$;M2+.#B<Y4RG4,("(:,/$#?6
MQ-3?4NV-K3<E@M;RK^?E%A-W:W-<*E:J4TIFXJ3`DC[3IN!:VZ)AA<HUZF,4
MVI5$"J"Z^`04,/>KQ@>?//;R8OWE7XK[QM,@6J5[6>G/J9ZC\?H"EF@7:]H5
MC=>;(J:3B\3%B<R!@0FYV>?>X5F5HFU1C2`4#&5'O,'I3RY^HEY9:4V?]0V%
MH*NF5:?X7ZT\?]KU]C9J39'MBMK/:<K'-9>J/Y)C<F$>U130=J>V_*W,HF)$
MP!(1,<P!<IOS9WY8A^HSJ'943IVT-M.>&%)\BJ8D2ERRU8=1FSM</;%/ZPO$
M!)V5Z-SKQ$BBT,\]UBLND8YO;((@4H=(BO-WR5@XOQ1UII]OHC658O/TN[1Y
M4JQ26MIB2B*9/ZRK;9Q'5BCQ#*X1;=&LNDA00(T<G4%JC[@E44,4H8':*UYE
M7#<UY^C%LNTZXU$]G?)ZG;EGYB0E*@,A/ZXLT'KP'4N]U9:W\B9]3VEE`!0>
M`JDY_L8`'(B'.!TJR?4.\F+#XS^>K&U2JNA_)SQZ\?9B\/M=RNN0925>75LD
MFQ:WS5ML._>P&P-63]6%LE&R@@+UC)',L;WR&1`H90C?(/RXUD7Z5WC_`*[O
M>N[%(>4VA+0XL-HV/1)!<:\]I^I*U;:[+A\ELZ#Z6<1Y)8$WB:RWN2:J/N&4
M1%0X8'`\M//;RR\5(ZT,IBR:1O-YT\EXJ!:XG7T%*2D98_U8LHUK9,ELYC(.
MDG^G6LD]<)EIS9N_=/7I$CN%D3H=W8%UGMF;VF?J.>=M5/M%LMK[2G@[7K?3
MM?R](B)FNJ(7.&F)Y]$R2"RZ9'OOSS)([QTJ"CAZU(#4`32+@8I\8O.3;MDU
M9X/Z>UY7=::34V)X.;H\G9^7I&NF3:DQ)]92\O`U77E&I3AR,-`U]623!Y*F
M[E7!D#D31.B=;W@"^1'U%_*?=LQX(IZWD:/JAEY7>(&]MRW5O/4-6Z&K-VT]
M%2*Q7U/%U-0JQHFP/V/N-D7QUTB-%"&,"@]#AL[^G-Y"7;RJ\*]";]V.WB&U
MYV'57KRSD@&BK"%5E(BQ35=6>1S!9=RHR0?A$`N*7N&`AE!`H]H!@>V<!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,#&^WM?-MJ:TNFO7#TL6-K@GD2UF18I2"D'(KI\1LXW;*JMQ,[
MB'P)N$C)JHK)J)@9)1-0"G*'E[PFMVO6]6FM-4N\3^PWFK9ZQ1EKL2U+M%0I
M4-:G=@E3R6LJF6T/YEV5Q1DVQ?>CS2,DY;-G**ZRYOB2@`9C\I:-O;96EK11
M_'+:T1I'9]B/',6.SY:"6L:E5B!>I*3CN%BTE42'GW#!,R+554?;0,H*G`F*
M7`^?"\T'ZOOA+*3&P+GK_0/U,-4,2KNK1*/=<5K]:%F*4.V9N)2173KR5_=+
M131F1L4H'L0?#)@7L*F!>T/6/@7]1CZ7VUKH9A7M1ZS\.?)5^JO%R]5N.N*9
MKV;>RHJO?BXR#V"PAHAK(K*E**AVKDT>\,*@%,W$P#@>3_J_)VGPO\^O#7ZA
M<!(R5JA)V=;:PN$':W$19H:J1446/0D8[74#+M"*5MW8ZE)R;D7R"QE$I`IE
M0.F"@B(7:VNK+]-WZK!]Q:DU9N;9'B=YFZ_CK9M=OK6I6_:A(ZY2\G(&_,S"
M38H6!9_)L9\22)6:;DA2QTHJF@';[90#T9Y!?7=JGC9L2'K6T_"KRPI-'G")
M+L;OL"!A:,_DVADT%5G<!591VLG)BU(J(J-SR;=T0`#O2((B`!L3\6_J+>(?
MF.[9PN@]J)VVVJ5S\T2]*6KUDCK+4XT#II*DM:;F*"+AW*3A4$B@9V<BY_[R
M94OXL#V_@,#`/DGXTZK\L=9/=.[IC9>=UW*R47*3->BK#*ULDPO"NTY&+3D'
ML*LUD%FK.103<%2*J0AE4RB8#`'&!V68TM0+1J1YHVYPI;OK.5IPT.<@+:[<
MS!IVM"S"/^`E9!4R;UR?X4A0!<#E7(<H'*8#@!L##K/P=\<TZ[M>LS5%"ZM-
MWUFMTG:$E>YR9M-BM-.I<:2)I=;6GG[GYDQC*DS2(9@#91%1)R7XD3F<B*P@
M>>#WCO.4G<%%N%,7OC#?C6M,MMS5TL$S.6VXM:3&L8FD).[,=PA),1IK*-0^
M6&:&;BU6(*X<KF.H8+MI[PZT?H_9%GV_28:S*;/NM9K]-MMXM6P[Y=9VQ5NK
M-T6\!'RBEHGY)JN,6DW*5)0$@.4.>!#N,`AC[>'TYO$SR)N6R+[M;74A/67;
M-,JU"O;MG>[U`-9VOTJ01E:J+B)@Y]A$_,H%^@4[9P*!E$Q*`AP;D<"K:OIZ
M>,]UL5QM5CK-I>3>P-+1OCK<W1-E7Q(+!IB*1CD6U*?)EFOQ-E!C$U%7!1*\
M56,HH=8QE#\A5LOT]_&"UQ5`B9FDS"J>M-2R^AZV^8[`OL+-.M,3;)-@_P!9
M6B=AK`RE+;4#H(D$C6047!,Z93%$!YY#T+K/3-%TYJROZ9UG'.ZCK^I00URL
M1$?-S;EU`Q/]:*+:-F95](2Z/PGO#[)A6,9(`#L$````/---^FYXB4.L,:)!
MZS=/->QM_4VJTUU:+U?;;K_]2EEB+J75[3;!8G\'+S95DRJIF>)+I(KE*HFF
M4Y0-@9P=^-6IGN^X?R;<UYPINJOTAQK>%MH6&Q)MV%&>.#NWE=)7$9).N*,W
M;P_OG$[4Q_?`I@,`E`<#"^V?IR>(>[[3L>X[)U4,Y,[=_)RNQRM+M?ZY$VR2
MU^4J=/GI6"K=FBHAQ8X)`@)(/A1^)(G^'NZCR'DO<_T[]J7+>NX-H4G=FZ]=
MN+M`T"#U\\U#Y)V764=7OR/1&E5C93:E7D*?<%KH^;R:(KB=DZ20<LP!,Z!'
M!EEU0V02FDVNP=0U'66X;#,WU>*CJ4K:K#'3$]2'-NME.)&/4[(Y+4I6+7;I
MNK/&$D?@_=,V]T"]Q#`7@0L&X?$O2F_+)JZX;6K,A9K1I28/8=6S2-TO%>?4
M^?4.R,I.1RU:L$0<954L<B!UE!4,H!.TW)!$HACZ\_3R\1]DRMUF;KJ".F76
MQ[=!;"O,>G:+Q#5JR;`KH)IQ=[?U6$L<?737(B*)"*R16I73@H""AS<CR%PN
M?@/XM;%E]NSUZUB2RRF^*[6:CMY9]<K^1&_5BE.&+JHP<XT:VANV^75]:-2%
MLDB5("<&#D0.<#!SB^#'C*21V)+!KDQY/;FM8;3NRY!:YWU9W<=8U^+9PL+3
M955:S*#\KC(I@1LD9+VW'LB<HJ""B@&#B-O`CQ59+U-TSU:FW<T74TOH>H+D
MN-_]VNZ<GD7C>9UW&G-:!$E>D47IRJ$.!E.WM`#_`("=H<F-\$_%N%0TFWAM
M5L6"7CBUG&&C4262YJ-]<,+*)@G6,(W6L2J:C26;F%!=-S[Y3MC"EP!/PX'8
M&/A_X_,ZY:JBMKJ,EJW<]?):CGHRQRMEM)5M5(F>K(ZZ8.+',RCR%I[9S)N%
MD6315)))=3W"<&*3M"E`^&GC=69'2DO"ZOBV$IXYQ\K%Z4>IS-I47H#&>*))
MU&*,YFU_B1FDN$W)W?Q)UD2E3,(D*``'7]G^!/B1N2S;"N6R]%4NVV?:C*K1
MU^FI%2=1=V1M256:]3.\"-EF*2+^#48)%1=(`DZ]LO8902B8!#MTKXA>.<W?
MI#:4CJR!4V%,:U'3\O;&[N;8R;_6_P``M%EJ[@64FW1501C'*C9)P)?C$4#F
M*18H#@69#PD\865&HFN(O4L'$5#64=986@QT5)VB,=U2OW1-PA<:Q#SK"=;S
M[>JVELZ42?Q@N3,7*1^TZ0@!>`O4UXB^.\_8:#:Y#5==3G]5TF1UMKA_$N)N
M`_)=`F8Q6%EZI7FL%*1K*.B).)7,W73(G_6H@4IAX*3M#(>GM-:TT%0XK5^H
M*C&T37\"H\4@ZG#*OCQ,1\P=*O7B<>F_=/%6R"[Q8ZHIE,"8'.80*'(\AE#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`"`#T$.0^X>N!JL\SM&76H;%@?+70)YIGLR`82E9F63JXH
MUC3L2UFWE<D)+:^X6;U[[SFA5.!J[D99E!-B2LTLNW%=15)N1(0]5>*/EUJ'
MRVH:=MUG86KMW'KOXRPU]T<&=@B7\5*R,,=TZ@W*II5G%31XL[R/.X*1=5BL
MD=0B9S"0`]3@!1X$`+TZAT#I]G3[AXP-:WFW]*GQ1\Y&+N3V!5"4W:OL&+&[
MDHK5G%7,CA-%1-B6R$!((^YQK110#@@_(=0.PH)K)]1$-".K8CR"\6O+;5?T
MPO/2GZ_\R?&.\RJMYUQ9=F)JVE+7]-CVD^+O:%=F)LSB3J]?K`1SA.=C98WP
MC0HJG17!$0,</4^L/"Z?VC]1S5WD?X)6VT:F\#-<I5^2FYR)N%F1U5LZX5M[
M*PEKJ&C:.[F3M)G7L]&^RQ<2*+9.`]U)R+45C%+R'T2[1TWJW=U5<T;;]`J&
MRJ<[53<+5VYP#"?C?B$5`42<HHODE?AG*1@X*HF)#@`B'/`B&!9M,>/.D/'>
M$?5O1NJJ)JJ#E7XRDM'4>N,(%*3D?93;E=R!VA"K/%4T$P*3W3&["_P\=>0S
M-@,!@,!@,!@,!@,!@,!@,"':`CR(!S]_`<X$<!@,!@,!@,!@,!@,!@,!@2B8
MH>IBA^\0P(>XG_A"?^T7_=P(>\B`\"JD`_=[A>?YN<"'OH?X9+IZ_P!83_=P
M'Q"'^&1_QA/Z6!#XAO\`X='_`!I/Z6`^(;_X='_&D_I8$HNVH>KEN'[UDP_Y
M6`^+:?YTW_QR?]+]N!`7C0/5TV#]ZZ0?\K`A\<R_SQK_`*0E_3P(?'L>>/C6
MG/W?$H\_S=^`^/8\\?&M.?N^)1Y_X^`^8,!_Z<SZ>O\`:4>G_OX$/F,?_GS/
M_2D/Z>`^8Q_^?L^GK_:D/Z>`^8Q_^?,_]*0_IX$/F4=_G[+_`$I#_G,"`R<:
M'K(,0X]>7:'3_P")@2C+10=1DX\`YXZO&P=?7C^^>N!3--1!>/\`6L;U#GJ_
M:!P7^ZZJ^F!1_,4%R(?.HC\(\#_K1CT$`Y$!#W^@@`\X`;'`!_\`6X<>G_6C
M$.1^[JO]V!3&TUL!`/S!!=?3F7CPYZ\=`%QUP*`W*I@<2?F>N=X#QV#.Q8'Y
M^X2_%<@.!$;A5`,!36:O`82B;@9N+YX#[0`70"(?MXXP*0W>F@/::V5D#=>2
M_F"(YX#U'@7@"(`/K@2&O=+*43C;JL"8`)A4-8H<I```$>1,+S@`^\?LP)!O
M]&*/!KE4RCZ_BLD*'\W]MYZX$AMB4(AA*I=J@F;IT-9X,!Z]?07P#Z8$GZDZ
M[XY_/E+ZAR'-J@NH!QR(#\>/0.<"4=F:X#J-_I(!QSR-K@```'[?]H>F!(;9
M^MBF$H[!HW<'J`VV``0'UX$!D.?3`@.T=:%X[]A48G(\`)K=7@`1X$>`YD>1
M'@/NP(_J?K7CD-A4<2_W06VO\?S_`#'`E':6M`$0_4.B\E_B#\WU[DOH/X@^
M8].@@/\`+@0':>LPXYV)1`$0`>MPKP>OW?ZPZ@/.!']4M9CU#8E%$/7_`/+J
M]Z>O/^T<"0-K:Q$H'#8M#$A@[B'"XUT2F`2]X"`_,N!`2CS^[`IAMO5@]/U*
MU_R/H'YTK?(AR`"(<27WF`/Y<"4=O:I`3`.S=>`)1`IN;M6@[3&Y[2FYDN@F
MX'C]V!`=OZH*`";9VNR@/(`(W>L@`B7CN`!&3#^'D.<"E^LVH0-V#M36P&`>
M!+^>JMW`(!W<=HRH#SVCS@!W/J(/3:6N#<>O%ZJH=O3GKS+?<`_S8$/UIT]P
M4WZK:UX-P)1&^54`$!#D.!^:B`\X%$^\-,)CVGVYJ\IA]"FV!4RFX]!'@TL'
MH8.,"`;RTJ8>"[?U<<>X2<%V#4A'N*/!R\?-^>XG/4/4,"J7=>G#&`@;8UGW
M&`1(4+[5!,<H=1,4H2PB)2AZ_=@`W9IH?<XVWK$02`!4$+]5>$^1X+[G$J/9
MR/3K@2J;NTRB!C+;;U@D4ABE4,I?ZH0J9SB($(<32P=IC"'0/MX'`O*&RM?.
M:^\MS>]4Q>I1[A-H^M*-J@U:ZS=*+MVI&SN;(]-&-G!W3M)("'5`PJ*D*`=Q
M@`0[O@4U$P5*)!X[1_B`2@8#%X$!*)3<E$!_:`X&K_R,\"[1)IS]N\6[K7=;
M;$,,_+Z[86R*D5JIK/9VPKI!6'9FYZI*5MRUL1+O98>,625;R82L<JIV$33;
M(&736#%%C\PO*SP[4?U7R&UF[VS7FQ]JR5*W(R8.XYG,ZWU;!2\XVL>T+)1J
M_.5^KWN]&+'Q\1!)0XN'*@K.EER`((@%XG/JJMG.B]_;'K>E)EO=](^/B^YE
M:K*6RN2S,\H620KKJ%EV\*Y):8F-A)9<SH[E\PCSOXIN9TW3%,Y#8&MC4T,W
M^I5]-O<=@J&Y*?(?44\AG3^M7YQ<[-#5JT##5.\)3Y=`T.-.Y"0INE9:DM"_
M#-V20M'1W*ZKLRIQ5.0-OOTTZSYG:OT/K?2?D_J+5>O(W4-&84.#G*?LE*UV
M*V$@OA6D%(NJU!5Q.L0+/Y0!DW)PE5G"KI(#@B4%#=H;+<#JMHIL+<&R;.:&
M7!!%<'*?R:QV*LN06!(R("9]6I6)>J)@0P_@,H).>!XY`!P.HETK1"!P'YT$
M`#@._:.T51]0]14N1Q,/3U'K@2ETC0"G.H"=R$R@\F[]I;1.3G[RIGN(ID_X
M(!@5`TM0@+V^U;N.1'KLS98CR/\`OAMPF$/V<\8%-725`6+VG2N`!T_O>SMG
MI#T``ZBE<2"(<!]^!,&D]?E*!00MO`??LO9@C_*(V\3#_*.!2-HW7AOXFUL'
MH`<!LS9I2CQQQR4+AP8.GV^H8%8=)Z^'OY:6414'D_.P]B<>O/X`_-?]7U_N
M>,"A^A>N![^YA9#]PA_%L/8QA#C^Y$]M-V_\'C`@&B=:`42A%SX%$QCB(7[8
M/>)C<=PBI^:>\>>/OP*`Z`U<*WQ`Q$\97DINX]_V&<`$`*7DI#6L2%$0*'/`
M=>.O.`'0&K3<<PLST*(<A>;^41[N.1,);2`F'IZCR.!3_P##UJ@>.8&4-VE`
M`YNU]'TYZ];0/K_/]XX$%?'G4BX`"U:>J@`@(=]NNQA`0^XPV01`/V>F!*;Q
MUU`8X'_*SGN`Q3`/YJN?(&+Z"'%B`/3`@;QSTZ82">J+F[#B<G=:;D;@PAP(
M];"//\O3`G/X[:=4'D]0$YN0'DUBM0C^'^'J,YR/`!@2&\<M,F-WFIA#&Z]1
MGK0/0>.>GSOCGI@!\<M,"4"?DAMV@(FZR]C$>1YY$3?..X1ZX')_\/NG1X`:
M-&F#M*7\3N7,/:7^'J:2'J`AZ^HX$P>/VG`YXH<2/(<?B6DC_P#&?#@3DT#I
MQ,!`M`@P`?4!*[,`_O[G0\A@%-`Z:4(8A]=ULQ#@)3`9HH(B`AP(=WO`8`XP
M)">/VF$S=Q=;U8#=.OR\1^SM$?Q*B'(EZ??@<P^C-1*@4%=>U@XE.50!&/+R
M!R`(%,`]_(<%,(?</.!,;1VHC"!C:[JIS`H*A1/%I&[3CQ^,O=SVFZ>H<8'&
M_0+2W<4PZQI@F(8AR&-!M#&(9,_N)B0QBF$HD4ZAQ@3_`*#:8$_>;5](,8.W
M@QJ]'B(=@&*0`$R1N"E`X]`Z=<";]"-,=W=^EE"$P@4HF&KQ0B)2_P`)>1;B
M/!?L^P,"8=%::$HD'5U#$@B)A(:KQ)B"(^HB46P@/(X$OZ#:5Z?]U&ON````
M!J<*/`!W<`']D]`[AX_>.!+^@>D>#A^DNO.U00$X?E&#X,8``H"/]B]>"A_-
M@4@\?='E,8Y-2:Z(8Y2E.(4^"[C%)W@4IC?!<B4`./`?M'`@'C[HXI3E+J/6
MX%4X[R_DR`$I^``/Q%%C^(>`#^;`JCH/20E(0=2ZY$J9N\I34V!,4I^TI!.4
MHL>TIA*4`Y`/3`BGH32:8<%U+K@`[N_@M+@"AW]PF$W`,>.X3#S^_`J_H5I7
MM[/TFUUV\@/;^3H`0Y#J`_Y!Z\X$!T1I,>\1U'K8PJ`8#B:DUT1,!@X$#<QX
MB/.!*.AM)F-W'U'K0YNX#]QJ/7!'N``*!NL>(=P%*`?R8%8^C=+J'(J?4VMS
M*I]OMJ#2:X*B8%#M(!#C'"(=@>GV!@3&TAIPQA,;56N3"(\B(TJN"81^\1^7
M=1P(ETEI\A^\FK-=%-V`GW!2JX!NP!$2E[@C_P"$!,/\^`#2>H"J%6)JW715
M2E.0%/R36^\"*<^X4IPC@,4%/MZ]<#DI:>U,B!P3UAKTH'-WG[:970[S\`43
MF_U=P)A`.,`.GM2\`'Z7Z\_"!0+_`-BZY^$"^@!Q'`/`?=@1_1_5'X_^['7?
M]8``</R37!`W`<=0^7>G:'&!$-0ZH*/)=8Z\+T`!XI=<Z]H"4H?[.`.`*8>G
M[<"0-.:E`W<75^N@Z]W/Y(K7<`^O('^6\@/.!(;3&H#&,<=5ZW$YQ,)SC1ZR
M)S]X=I^XWRSD>XO0?LP(%TQJ`@=J>JM:D+R(]I:+5P#\1>PP](L`Y$H`'[@X
MP($TKIPG';J?690*42E`M"JI>TH_Q%#B*Z%-]V!`NE=.E$!#5&M`$`$H"%#J
MI1`!]0Z1/H(`&!/^C&H!_CU5K8_V`)J)5NGW\?ZJ^W`E_1;3P]HFU1K0QB?P
M&-0ZKW$#GN`"C\IZ<&Z_OP)0TGIP#^X&IM9`?N[N\*#5`.!N..[N^4\]W[<"
MJ.FM2&.0XZOUR)TQ`2F-1JL)RB'H)#?*N2#SUY#`?HSJ#GG]*M;\AT`?R+5N
M0^[C_57V8$GZ*Z>Z`&JM;```(`4*'5.``0$#`',0/`&`>!_9@3!IC3Y3=X:J
MUL!_7O"BU8#<_?W!$@/.`4TSJ)0W>?5VN1/P("<:-53'$H_^B)CQ!AXP'Z,Z
MBZ?]UNN>2B!BC^1JK^$P``%,7_5'`&*`<`/V8%0FGM3D`0#6&N_Q#R/%(K!0
M$>..>"Q8<B(!]O.!/^D6J>0$-9Z^#C[J56?_`+7S@5#:HU>;_P#G%!`>@@(T
MVN&X$.!Y#F-]>F!.&J]8``%_3BA\!QP'Y/KW`"`"`"`!'<`/4?Y\"?\`2_6O
M/(Z]HX].``:E7^`Z=O(#\N[N1+T]>.,"I^FFN.O_`'?TGKZ_]E(+KP("'/\`
M8.O`@'\V!4#76O@]*)30]/2L0@>G4/\`H/V#@52T"B$+V$I52(02@02EK<.4
MHD#H!.T&8!V@'H'I@1"A48..*94P[?X>*Y#AVASSP'#,.`YP(A0Z.`\A3*H`
M]W=R%=B`'NXX[O\`(_XN/MP*OY+J'_ZM7`_9\BB>/_D^<"9.GU1,1$E9KQ!'
M[20<63I]WX6O/I@3_E.L@/<6NP!3?B_%\EC>?Q=#<B#<!'N#U^_`J%K%;(4I
M"U^#*4A0`I2Q#`I2\!P':4$."@`?9@/RQ71ZG@8,X\B(":(8#QR/</']1ZB/
M4?O'`B-:K_("6#A2\"`_[)8#SP//K['0?N'[!P*I8"$)R)8>)*80$.XL:S*/
M`^H<@CU`<"<D'#$#M+$QA0^XL>T*'\Q40#UP)OD\1_U5&_Z"U_YK`K@P8E0,
MU*R:%;',!CM@;H@@<P"4P&,B!/;,8#%`>1#U`,#EX#`8''<^WV#[O=[7:?W/
M3V_;[1[_`'N[^K]KM]>[IQ@8DLWZ)_)MC?FX==_(_P`JK_JS\W"L?"_DSY0[
M]_\`/O>/N?E[Y#[W^7_U'PW=V_AP-6?@I_Y)WZMOO_!-^@H;L^,<_`=@38WS
MX;^V_%?IY^IHA*?)?A?>[_D/X/A?XOZKC`W7X#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
A8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g854281ex99_1pg001b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g854281ex99_1pg001b.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`5`##`P$1``(1`0,1`?_$`'D``0`"`04!`0``````
M```````'"`8!`@0%"0,*`0$`````````````````````$```!@("`0,!!04&
M!P`````!`@,$!08`!Q$($B$Q$R)1%!46"4%A<8$7D3(S-%0EL=%B<B,D&!$!
M`````````````````````/_:``P#`0`"$0,1`#\`_?Q@,!@,!@,!@,!@,!@,
M!@,`(\?;_(!'_A@5WG.S>N&TT]JE&1L^Y[E&NR,9.M:?@SV\(5V8?$R%FM@N
M(_7]251,(`HG*2[18O/]P1],#C$LO:>RE%2)U?JK6C0QA^,VPMA2]QL($$WT
MBZKM!KR$`W4`H>I4K$X#D0X,/K@?<]2[1N5/F/NS44642@(L8_0=B?)$-X#Y
M%*\D-YE6.7Y!YY$@?2''`>^!'UIVOO3K\>#L&[D-;;`U%)V>K5"?V'KN,L5&
MLVO7MRFV%7@+#9:/8)ZYQD[45+'*M6SYRPE6SF/(X*L+59(BIR!<O`8#`8#`
M8#`8#`8#`8#`8#`8#`ZR7FH>OQ[B6GI6-A(IH05'<G+OFL;'-4P]SN7KQ5%L
M@7]YC`&!BE-VMJ[8J\@UU]LF@WMS$E3-*MZ;<*]:%XPJIC$2-()0DB^49%5.
M40**@%`PAP'K@?/9FT*CJ:N!8[<]<)D=/VL+`PD6R<2]GMUDD!.6+JU1K[$B
MLC8+%*'3,"+9`@B!"G54%-%-10@0PEK/8>[50E]Z2#JI4)<IAC=`T^;6;HNV
MIC%.@KN.[0Z[=_:I(Y!X6@XQ5"`1^I)<\H'"N!9"`KL!5(=A7JQ"1%=@8M$K
M:-A8.-9Q,5'MR<B5!E'L$6[1LD7GT*0A0P.YP&!0_M3,-]VVNF]-J<H,G-6:
MQT38V]WK1(R[/6>CZ1;XVX&_'7I`,A'67:\[6F\)",CC]Y7;*O'H$^!H<XA?
M#`8#`8#`8#`8#GCW_A@0)=>Q-'K$^]HU;8V7:^S&(-_ONN]61B5FG84'@^+5
M:X2:CMA4M?M5A$#%4GI&.^0GU)%4]L#$@E>Y=F5;/8VK]?=3PZR!3GC;A-W?
M;%K;G-R(E?HU(FO:RU6('`&3;23],#<\+&``$0R;K5MFR[BUV]L=JC*RVF(2
M\W:C+3=&D7LK0+L2F3SF$"Z41](I$?JUR84;G*4BIEOA=(+)$7<)D(NH%@L!
M@,#X.7"+1NNZ<K(MVS9%5PX<.%2(-VZ")#*++KK*F*FDBDF43&,80`I0$1'C
M`JN_VKL7=*;J&ZXI,(.J."+LW/8^V1QWU8)YE,@JYTW3ERHJ[2D&:AA%*3=G
M:5DJI`,162*!VXAW,'U3U859C-;,2E]_7-FB!!N.[W3.[+IJ^(`HM"U,S!CK
MNG@H<!-X0T.P#D?J\A]<"GW:6QZBUEV:ZO+4"`BXW:6OI:V7'8R6M(!D2WOM
M03U&LM0KFJI*-@2,SS,AN7:\C"H5V*>#X*N8IP^)\:+!PNF%P=3ZILKJQ?UM
MW;]S?[:DF;EM7*RU<ED:MHNKR)""K2Z4KX%1?6)^D4OYAL`%!>5<E%)(4V":
M"(!9;`8'36&Q0%2A).RVJ;B*W785HH^F)Z>DF<1#Q;)+CY'<C)R"S=FS;$Y#
MDZARE#[<"H3K<>W>P7R0O6.&6I-!=>*;[L_LJN.$8I5D*@INCZ2UE,$8S.P9
M04_J:S4LFQK)#<*I_BA`%`X3IIG1E$T97G\+4$960E+#-.;3>+O:Y-6PWS8=
MP?)$1?6N[69T0CJ8EUT4RI)E*5)HS;$(W:HH-TTTBA,6`P-OC]0&\A#Z1`2^
MGB(B)1`P^GEY%XX#UX]1P-V`P&`P-!$`]Q`/7CU'CU^S^.!0WM1N:+B]FT'0
M-DW!&==Z9<Z!<]GW?;,G9X.ER\E6:5/5*NN=::[L\\L@UA+/85K:5>0D4!-(
M1T6@868$<+$<MPX6NNR.F&M?1HG2K45HW*V9'721<ZZK+JF:@;R''R+2EIW=
M>V<15Y=:0-Y*N'D>M899V<3'^)<YA$0K)NOL%'21)YON:]R6YDJ\Y)$VGKAU
M4=JPFG:_,2!#I-:AO3L-.2$,O<9EX<11)7&CF,=22O\`X?R^\\@*8/1KK#9+
M_:].UJ8V'HMCUPD3D5:0&HF5@83YZO2V7@WJJ4@6+A(&.K\DK&$**D4DA_MX
M`5,X@?R(0)Y=.VC!`[I\Z;LVJ8D!1RZ63;H)BJH1),#K+&(F45%3E*7D?4P@
M`>HX'(Y#[?;W_E[X&#["V/3]6UAU;KK,)Q,.V6;LD?!%=_)2LL^-\47`P$,P
M2<RM@L4PY$$F;!FBLZ<JF`J9!'`I3;;O4;LJA/=N+Y1]-:U0<(R=8ZUV>\UY
MC8;*V1,5:.FMZMF\@9>>>*#XKHU!B"\4T,!?Q!206`$FP2D7MM6)5LBTTQIS
M?&Y"@@"$:XI^KI&DTSA'AN@FC=]NJ:VIYF1#%\0.T<N2E(7DI1+QR&+S?_V;
MM",>+34WK7IIKY!JN\GI>+DX_=&ZF\2T145DE$IJ7C(;36O#)M0,H+PR%I^[
ME)Y`4HAY8%7NK<AU)I$Y);MEMKTF-;33V0>:I_J'LV.M&WKTUD&0,9OL)LY_
M*R+BUSFP=F,0^&&252(E`5,B+5F@U^^O$<"\J'<;0#\ASP=CMMI*0W@!JAJ/
M;UJ2./MPDX@*(_:J\C[>)QYY#[0P(\V=^H'I#440E.WBM;QAHQRX*TCU)+2M
MY@74PY4$A44(.+M,=`RTXNN<X%(FT06.)O3CT'@(^GNZ>^;HQBE.O72/L#(Q
MLPF)EMA;DKT!KF$@D#D\TW[77,M=(K8EP4X$O@W$(9%7R_S90#RP.FB8Q:5F
M8VY=@M$]K-_W.*=IR,0G9Z7JQKJNFR:)CD2=T73T/MF0K<>Z0Y*9&1D_QJ;3
M$H&!\`^F!9Y/LZV3\BR&A>S\8*?`#\FFI68Y]1`?`]9?SQ5/'CGDHB`\^G.!
MR"=KM9I`(S%<WE6Q*H9,P3W73>;4I1+X<F^="@.FQT_K#ZBG$/?[,#1/N-UH
M$_QO=L0D"H'/F2V1]AIQDA`PE,"Y;5#0XH&*(>H'\1`/7VP)"@-[:1M7QA6=
MPZNL!U?#XTX:_5626-\@B5,/A:2JRH&.8.``0`>?3C`E%!=!RF59LLDX1/ZD
M504(JF;_`+3IB8IOY#@?3D/M#^W`UP&!%VV-QT#2U?;3][EU&II602A:Q78I
MB[G;C=[&Y*8S*KTBIQ23J;M-A>^(B1LT14$B8&54%-$AU"A`D@EV*VW&NIVW
M6I/J+J5)B[DG49%+5J;WHY@D6[A9=[;KU*DF=;:E(DS3^99"-;S;MLGR(R*!
MRF*4/+0-X:*C+7+7_JKTXA^U,K"D*>;[%]A=O`:9=1YERD<VA+8&VF%\_IW2
MW":?RMWLX^JI)-,`-&LG2!B*&#-*)O;L=^H]4CW2)K:&A>K)G$A!F83U^-5Z
MY8#P2CF%L[J^;!J#R(OU^A&LRS<)-JY63U6)<M2`,E.J>9F1`GO7VQN@_7V3
MK\<KM.-W5L.K,#M:R&K-:SFQJSKU/Q(B\B=7:_T/4+-0=6"H)A!840&==E./
MWYZ[-R80E>S?JI=(J,9FSO&R[=1YR3165@ZI<M(;SK%ML9&QRI+%KE=F]=,Y
M.=434.4#%;$4$O/)N,"NU_\`U4^OVS8&9H[70NU;31;*U>0DY-[UUQ=-5ZJ?
ML%2E*J#MZ[IUNLR[41,4Q3$A@.4X`)1`X`(!!6T/U6XJOUF*J.M^Q.@I+9\T
M8*SKG3^EHV7O-F*]8L3),S;#W#V$F=<TFAPS5-N07#^7AC+K`!A2(N;D<"O=
M:US$;E?5C9WZB/ZF438;W#?B9J[I_JEMIE8[3"NIU,R#V(BC::8./N+S[H8&
MRR=>A%WJY0$#2AD^4P#T>U/O[]/CJ-2ZU`4[7VYJ:27FR5V+GK7UA[#/MB7R
MVRRJCA)FO:['K<]EM]AE#\J)HD75,"8?0F1,O!0[20[T;%V1(R+&MZYWCULH
MS1TLS3N-^ZF;WV1M.Q$3.0H/JO2*]3'-&JC!;D?B=34C).1X'SC```Y"M&X;
MKU'OEZUAJW:.W-\6IO(ROY_W1;NQ,3NZE1T/0JPY(O&4]C1%J;K[75?;[4N`
M),5G",05$(=C(HBK\IB<A>38/;[HGU?T=)[AH<CIV:A$7J5<JM0T"C1G]DNU
MZ?IF5BZ/7H>I`4Q)M\/)U06*F5HW`RRO!0]0CS0L)W][(Q4K?]WW-WU0J%Z%
MLYA]=TIDPD=KQ%3(188^$:OK$R?PVO'+E-S\SV2<LY"R/%A`"EBD4D6Y0NSK
M#K#I74\@-BKM/3E[XN0"R.T+S(2-^VE*G^+XE%7VP+<YEK*4JP<B9%!=%J41
M'P2*'I@3Z`<!P'/\Q$1_M$1'`UP&`P-IB%-R!@`P"'`E-ZE$!#@>2C]/M@8'
M-:IU=9!.-BUM09\50$%!FJ=7945`'GD#B^CE_,!Y_;@1^YZL]?%5P=,]55>N
MNRE$I'E+2>41V0!#CZ'5,=P+@@@'L(&`0_9@<T-$0S0R8P.P-T5TB(A\*#7;
M%OG&J90*!0(#2ZOK4V,0`#V,40P,I:4RV,0;D2VO;GR2)1*<)J&H;Q5QR<#%
M%9=A4XE3R*0/'DO'//(^N!(/QK?Z@?\``^/_``D_\;_4>WO_`-/]W`\YK*SW
M+0NV>R-LR76:\]ADI2MU:L==+93+AJQA$:LJHP+?^H=5E(O8UVJ+NFSUKNI%
M7CZ::(/_`,2C?NC83E*T^`0R2_Z`W9W`U_:-?]E+&EI'4UX@W<-+Z>T=/HSM
MTDV+LR(@E>]T3<`DT,D!D>58J"AV[94#&27>NT!,F8,CU'T&T5JEO6T'8VW:
MB=,!'\F1VTI:.EJ=3E$$P22?5;5];AJKJF'G2%`!_%209I7R^K[SR(B(9Q+]
M)^HL_<Y+8,YUOT[+VZ9D!EY>5DJ+!/2RDN;Q%66D8UPT4B7LJX,4#*N5$#+J
MF#R.8P^N!8F$K\'6HUO"UR'BZ_#M`\6<3!Q[.(C6A.>1(U8QZ+=L@41]P*4.
M<#%=B:FUAMV')7]IZ^IVQ(1)4R[>,NE<B+&T:.#`!1=,22K1T+%WXE`/E1$B
M@`'O@5/V-^FWU-O="L5$B-:Q&M_S&@W9*6BDL6`6.%9@\;+2`5HUC:S\/"OY
M%@BHU!T1H*S<BPJ(B14I#E"2]6=).IVFZ8TH=$Z_:J8P+9%%-RK*TR#LL[.K
M)(_":0LUAL+*3FK#*."B(J+NUU3F$P\<`/&!-M)UCKC6<:G#ZYH%*H<2@+@S
M>*IM7@ZO'HF=+JNW/QM81@S13^\NESJ'X+]1SB/N.!5+959VW3.RQ]ZQ.F'O
M8JONM<P%%H\7"72E5JS:0E&TM8WM\E(F'V')UZNR#79C60C".I)I(DE$B11&
MIT3-C`8`RP^XNU,HY(S@>FZT,"A#C^*[)[`:T@XQL?R`I/F2UXCM265]!\A`
MC?V`0\@'C`\RR[[[&));([#,M@:=JUL["3LY3=.4:HT*S;4O4W1.O*EDJJLU
M"3-XM.NZI2=/,YE.:LTK9)J),S:-9`%E"F%1JW.':?IM=/[-MRV-_P!0WN+(
M1&U=R6!`[/0ZAJC7*Q7JQ0T'"IF&P&=:@H*"9J3MC4.HK$NW;<SMM&F36Y!5
M<OPA[M@'&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!M'T]1Y'UY#TY\?3]P<\?
M\\"HW<C;=IU[JQ"GZJ:EE=[;YF%--:*CE!6;,6MWL<)*.W=NG)!--7\/KFNZ
MO&OYYZMXF,*;`$B%,HH0HA0>7ZEQFJ*5U[Z8-K1*;#VAV/3CZKO?<,D"+&=0
MZT:/B8>:O5'JC5N`?DJASJI8Z";L&H$3=+RSIVZ,L]755,'M/',&44P91D:S
M;1\?',VS!@P9HIMVC)DS0(W:M&J"12I(MVR"92$(4`*4I0`/0,#F8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`XRK1NLHW6400459J&6:J*(I',V6.DHW46;G
M,03H*G;K'3$Q1`1(<0'T$0P*"5\Z]B_4^V.X7(FX8:SZ6:UB(DYD3*#'2.SM
MP7R8FSH.#&`B"DHRHC$IRE*)CD;%^H`#Q$/03`8#`<@/L//`\#_'[/XX#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8%-XZ/1KG?NSOE#'2':O5&J'CP.!P2=O--[
M4LS:=*@<2`D*S5CMZ+$Q`,)_$_EQP'.!<<0Y#CD0_>'O@:X#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8$%;II\R^<Z_V?46[AW<=06-U-I1+,A5'=LI$_'GA
M-A4MN111)-1[*0YDGS`IA`#RT8S`1*43"`2Y`6"'M$/'3\"^2D(F5;%=,G29
M5$Q.0W('36;KD2<M';=0!3605(19!4IDU"E.4Q0#N<!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,`/L//M^W`CR(_*OYREORW]\^_^3K\U?A'E^6/QCA#G\8X
E_P!O_-GAQY_#_P"W\?\`F/I^/`D/`8#`8#`8#`8#`8#`8'__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g854281ex99_1pg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g854281ex99_1pg002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`=@!1`P$1``(1`0,1`?_$`'@``0`"`@(#`0``````
M```````("0$'!08#!`H"`0$`````````````````````$```!@("`0($`@D"
M!P`````!`@,$!08'"``1$B$3,105"4%187&!H=$B(R06\#*1X4)2HB48$0$`
M````````````````````_]H`#`,!``(1`Q$`/P#[^.`X#@.`X#@?@RA"B`"/
M1A#L"_\`4/Z@^/QX&2B)@`1*)1_[3==AZCUWXB8/7]?`T1L+L)3M=Z2%EL#>
M0LEFG'I:[C;&E:3%_>,HWIXG_P"HIM0B$2+NWCYVH('<+@D9!@T*=RN)4B"(
MA5O+YE^X30MH-/'&8;MCF$8;09@G:F73^D5UM8&^.,2Q%(<3UGLUJR^H@A+6
M:[4]=%LJHLV0;Q9E7`I)E\>!>#P'`<!P'`P(@`"(CT``(B/Y`'J(\#QG5(4G
MEY#Z]@7Q*)A[Z'KT`IOQ_1P*-]H-Z\XW#;O7?6S4I_'1U;=[$1%%RED$[6/F
ME[B>F)%LN7ZA56"Z#A,:CCBL@"-AEBB4`E7*+-%0%$U0$+A\I9'I&(J';,E9
M$ER0=3ID(]G9J0,114Z3)IZ$2:MD@$[Q^]<*D;MD"@)W#A4B90$Q@#@1,P!C
MBQV*S2.X^R2",)D>:KC]'&-'EW*1XC6G"SL@R`PQ72H@S)D*U1R"#^VRANA`
MY"LTQ*W;#YAH'3Q%WN/LY??N&R[=^3$U7B9O7W3:,?D*B5]1V4N=/)^:TVQR
M`*:N0[$P%I'J?[QBT3`/H)>!;OP'`<!P,"(``B/P`.Q_4'`A/MQM'.X@_P`6
MQ-@^N1^5-J\P`X98EQ8X<F;QL<P:*`2?RIDEZ@(+US&%.0/YNG1Q(+I;Q;H>
M9S&\0J/RB[^XU@79O'F)9K=!AEZU[;8SR.2R0Z5&:4W'6K-6KK*!/;,X5Y$C
M]SU'TALXD`C#+^P=TLW("X"8XAP)*?:[PC7+19+-M_#UMY%8K85@->=,HJ<2
M[G0P359QV\N.998YTBJ+6O8*_?,S#MT(>\X0\1$PD4#L)0/Q_P#L'9!6'/[;
M_6_4RW-%)H">*L9EG9F-!-VA#*E,(E?5C!S1P59<G1DW$ZX`A@,#4>@Z)M[/
MV3:C)+#0O#MA>P\,_;LK+M[D.)2<IC2\5+.43-\914NBD=!&\Y,_G05;B8JK
M=AZG#P44`H654ZIUZB5>!IM2A6-<JU7B(Z!KL#&()MH^)AHIFBR8,6C9$I4T
M46Z"(%``#U$.Q]1'@=FX#@.`X$<=J=B('6+#E@R=+L7-@F"JLJUC^C1I16G,
MCY*LJIHZET6";$[67?SDJ8H&$@"*3=-54?Y2#P(IXKK-<TMPYD[<'<:U1\ML
M!>8EM;,WWI%,[L\8F(BK4,`XK9>:BJ%8JSETG%QD>V`@R;\#N5`,8WD0*E,-
M*99^XOEZU24N5_59G:.+BWN97;8Z_GKM]ONN3AS4+!5<F$B`5ADW:&>;*O9<
M"&3<!$$*Y$I4U0*(7K[(75_@+#E-Q/@2*BXW)>0E83!FO=5;(E"-@'ZD<+/_
M`"55F'0IUG%M-8KRKL?4@`T3(;L50\@U/;9T-0,3XJU/UL9DNVP-TB9"'Q[%
M2IDUC*23ER=[D'/V4G@@95&&82SYS)NE%!`7SU0K9/L/+Q"3&LFNE<UPQR2I
M,)"0M5MG)5Y;LG9(G3`I9LEY"F53/+!;)M8HCX$<O53$:-2])-&I2)E#_<)@
MD=P'`<!P,#WT/0]#T/0_'H?P'@4(Y`V\P98MMKWG_.M]BVV'=+;'-84UNQ5'
M_+V"_9BVA>L$$<E72G4%BJO,V:5K#9RG7H0Q42)(N%7"ON$'S,`1^W3)LMGN
MLTF[96I+NJYCV`LXX?T0T[7D$7#W%K6Q-`-?MDLV&:B=@\R)"4I-<$A,3Y6I
MHO2G#Q=B)B!=)I!I_5-,<'16,HJ17M%PDG25CR9?78+)O;O=SQ[./4?@FJHL
M9G#Q4?'H,8YL`@1NR;D]`,8XB$27^PM?>9&R1N-.-G=P@ZE)2NJ>DV.893WY
MK+]Y5E$F^4;15612G!4UQML<E$(R*0"1G"Q"ZQQ$J@`8)::J:]6BBFL^:<ZR
M4=;-F,N&:O;Y,1Y`-"46#;^*\!B6B&,`JH52H)B5,ZOH>0=$%8_903``F=P'
M`<!P`CT`B/X>OY_N#UX$8-K]L</Z@8N?9-R]:`A6;@YH>I03%DI,6N[VQT@O
M],K=/KC;^^GI9=4I3&33`"))AY*'(40$0JG^U-A[!&"]2;#N'G?!LAB;-Y)C
M)UFRGD[-$`JWOKN,1L#R493E49SXGD:Q#RK*00;-D&R35R^>E-W[ONIB8-N_
M;G<6/;G,&7ON'Y`BW+"(F#O,+ZS0;U<SA*K8PA)'W[7-1Y%!\4I"RRR"#9VY
M*4IEUVKGKI,Q2@$@/N:[,Q&O&OBL46R*URYYPEDL2U%ZQ2,YFHII/`"=TM4.
MQ3#YEY)UJK*+&9IDZ$\DNU3[`3@(!P&E.K;YDXIV?LN5,M4GJQ1VU`URPJY.
M1TAKKB3Y=-(GU(2G,U>YCOS=,CRR2($*JF=8S8HE*!R\"S@``/A_P_#X=>G`
MSP'`<!P.)G)F*K\1*S<W(M8B(AXQ_+2LH^4*BRC(R.;*NWTB\6/TFBU9-D3*
M*&,(%*4HB/`JDU0H7_V+EF4^X)F&OFDJJ5S(U32"BV-B1=C1,3,GOL.LW$B7
MB0HH7C+[YF#MLY.3WF<81'VC![@"4(W;YWZ?VMGI[%E(53?8,H5RB\/,3%5=
M+1>P.W=X5&$KU02.T,8DSC_!<<L\G)[HYF_S;+Q4`0*00"?V$\KX5U_37U/I
M(E+C_4/"\,OF;*:CN.94W'4N5JS7C*S83B5-9_>;<S^>F7"#0H_*)B3W0]QP
MDGP(N:L59#[A>>E=_<G0+\,2XPF)G'.H./)Y,H-SH0$KX6+-\XP.`HC,S$TU
M`C-#U*@HU]?(S=%0P72E*!0Z#OU$1]1$1['](\#]<!P'`<`(]`(C^'K^?[@]
M>!6KNO(R6?KUCK1"F+N"LLG)-\A;0V"/6.D>D:UUF80,\KZRR(>ZSG,VV-LG
M!,RF$!-'D?J^(D)WP.9VLR78F@X^TXUK=)U[+N8HCZ<67AF@(L,!X,B$$XVQ
MY(6(V(5")79QZ18^OH']L'#P?Z7JF`\"N7-V2JWA7/F.-9M:JVTM-\UGI+6@
M:X8P(9)X%@VGSA"N23>7<DN?95$*KAK%:CB9GI)<0`)"9,41\C=%")&>H]K9
M,!-\%TR\G3PBID<].LF;'%A+%/=P]OYQZK+YCRU8I==1NY=X+P8W0?R*RPJ`
MW46;-&B8F(1/V0^GG7.KX^I.#,55'%`^>-Z[1Z[%TQR+)U''D(1M&H%0E5FC
MUJR>).)93S<J>ZBF<QU1,)0[X&Z>`X#@.`X'3,BWRM8MH-UR3<7OT^JT*K3U
MOL3POMBJA#UZ,<RC\R!%5$2*N3-VIBI)B8ON*"4H#V/`KKU;FV.)==\M[Z[(
M**5*W;!++9UNJ$OX!*U'&#5C\C@S$3!N5PKYO(BFG:$29)F,=>:E5@*`J*=<
M#@<9V`=7M8\[_<(VL9+1F8LBP"^4+K`RAFH/:;6(U,[?#."(-%%VY3:BT1=,
MT3(@J9523?G]P1$@>(58:HZV97M=SF6$X_<FVIW8@T\U[;Y78'!)?4S63(YR
M62/Q%`O7+SYJ/R]F-%0J#@B:9!912:8&)[*953!O?"VNU:^X#MU%Y#C:LUA_
MMXZ/"YQ-KU6F1D0JF:+S6G3=6Q31(X5!!_4BSO\`<.GIT!-*>RW1.<PE<!P/
MHX12*B0"%[Z#KT[[`.@`O1?0``H`7KK@>7]O^ORX#]H_N_AP'[?^7`QU^D?W
M?PX#H?S']W\.!7/O.JOENY:XZ9QCT6[+/EW>W3+IDBG.8,"X1*QMMOB%#$_E
M;EN]E7B8?R/V4R2ZQ?CT`APU[10VMVOB\*),&[O7O4MY7,@9:2%!%2&N^=7C
M7YK&&-3)B!FB\5CB,`)N1;^H%=';)J%`"E["$?W1<XQ^2MC\,Z?1<(YO,'CU
MW`9XR?CYI_5#)^37KL&&M>$I(#"448F>M"WUF9(<H@2';&/Z"0!X'8]@$LC:
M^8=Q]IEC.RIVW??[@EL?'RKDUJ';NO1<HU(3+>3U2I"=Q$5*B5<#PL`4"E21
M00$Z8%.0P<"Y;!^'Z?@'$U"PW0F)6%3Q[6XZN1).@!=V#1$HO99\8._=DYF1
M46=.5!$1476,8?CP-J\!P'`<!P'`ISR7G:`Q/O%N%E^V(JRJNN>C&*"4N,22
M2$[EUD.^6Z67A8_W#I**/[=:X^&9$,3Q`?0@B(AT`;_UEC&^LF.,(XNN17MH
MS_L59[#D3(J,05J:3>7*S-_\QRC=)E1TJFJG3<>INVD2+@YU%?(6;=/S45`O
M`A#I'K5`N-N]W=^LFW<,CPT%E>^PF.[:]C3QT(S0J,<+6V6")CUWKU,S;'\*
MB>NQKLA_`03=J$`O8=!V3[7E9L&SV8,\_<\R41VJZRK.3.(M:X=^D9-M4,`5
M.5(B63BDE0_I*VI\R*4RI!$%#(+'`1*OZ!>/P'`<!P'`<!P*&/NI:^VZ=V(U
M,MN%+'%PF1,]WVIX0N%;N,8M)8QN41BR2>YOI<Q?DH\Z,RNVJ4Q7U1,W;*$4
M>)*%(`AX#Y!(_)-(R'K3AO)>6+=D,^9]U<_%K&"Z;>F\$%9@H&<O<L,-3*#B
MNH-W,J%0H=-D)-W.KF467>2#EL=T^6.)2`F$]<(89K&%,+4?"L,W(]KU/JC6
MM.3OTR.36!PHW,:P2TH14#E=+V*4<N'#@#@(',L8!#H>N!M&'AHBO1C*$@(N
M/A(:-;IM(V)B6;>.C(]HD'BDU8L&B:+5HV2+Z%33(4A?P#@<EP'`<!P'^OAP
M'`<"%.[>++Y<JEC+*.)H,+5E76K+-;S94*<+Q!@-[813.4KUZH;5XZ7;M&DK
M9Z187I&*JH^V5^DB!A`IC=A"_)&T"FQFT^E-&Q?C/(36QPKC+657]8SK0[CB
M*,K,]"5)"L1<[+!889JO:R48MA?*F1AC.O>=*MR%72!3WDPN>:^_[)0<B4RP
M`4#G*0"%.8"%\S`0#'\`,;OH.QZ^'8_'@>QP'`<!P,#WT/7QZ]/U\#UVR2B0
M+>XNLN*BQU0%4$P!(I@*`(H@F4O2).OY?+LWKZB/`]G@.!@0`0$!#L!#H0'\
M0'XAP(#[D^_BBY8%V]08*R4#@2;M%=S"BV!19]'X.RRQCX2VW%JW()E'88]G
MHN+EG"9"BH,>BY$OJ'`G)#343/Q<=-PDDSEX:88LI.)E(]=-VPDHV1:HO&#]
MD[0$R#EJ\:KD43.01*8A@$!ZX'*\!P'`<!P'`<!P'`XJ9^C_`$Y]]=^0^E?)
M._J7U/V/IWT[Y=7YX)#YO^T^0%KY^][O]+V^_/\`E[X$$M>:;5C1CRR::YCF
M6>#U[._*VQY;J'8;%AM$R4JJ6=-@J8L!*5,QM4<N_F!;'A)*6JQ5O5JD!.R"
<$_D@.!?Z@B)OS$"@/_AZ<#R<!P'`<!P'`<#_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
